A revised compartmental model for biokinetics and dosimetry of 2-[18F]FDG

[1]  R. W. Leggett,et al.  Occupational Intakes of Radionuclides: Part 5 , 2022, Annals of the ICRP.

[2]  S. Mattsson,et al.  Improved Patient Dosimetry at Radioiodine Therapy by Combining the ICRP Compartment Model and the EANM Pre-Therapeutic Standard Procedure for Benign Thyroid Diseases , 2021, Frontiers in Endocrinology.

[3]  Tianwu Xie,et al.  Internal dosimetry in F-18 FDG PET examinations based on long-time-measured organ activities using total-body PET/CT: does it make any difference from a short-time measurement? , 2020, EJNMMI Physics.

[4]  G. Brix,et al.  Double-strand breaks in lymphocyte DNA of humans exposed to [18F]fluorodeoxyglucose and the static magnetic field in PET/MRI , 2020, EJNMMI Research.

[5]  J. Harrison,et al.  ICRP Publication 141: Occupational Intakes of Radionuclides: Part 4 , 2019, Annals of the ICRP.

[6]  J. Harrison,et al.  ICRP Publication 137: Occupational Intakes of Radionuclides: Part 3 , 2017, Annals of the ICRP.

[7]  Sören Mattsson,et al.  IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms , 2017, EJNMMI Research.

[8]  R. Leggett.  An age-specific biokinetic model for iodine , 2017, Journal of radiological protection : official journal of the Society for Radiological Protection.

[9]  J. Harrison,et al.  ICRP Publication 134: Occupational Intakes of Radionuclides: Part 2 , 2016, Annals of the ICRP.

[10]  Wei Bo Li,et al.  Effect of blood activity on dosimetric calculations for radiopharmaceuticals , 2016, Physics in medicine and biology.

[11]  W Bolch,et al.  ICRP Publication 128: Radiation Dose to Patients from Radiopharmaceuticals: a Compendium of Current Information Related to Frequently Used Substances , 2015, Annals of the ICRP.

[12]  R. Leggett,et al.  A biokinetic model for systemic technetium in adult humans , 2015, Journal of radiological protection : official journal of the Society for Radiological Protection.

[13]  D. Minařík,et al.  Improved estimates of the radiation absorbed dose to the urinary bladder wall , 2014, Physics in medicine and biology.

[14]  A. Naum,et al.  Variation in urinary excretion of FDG, yet another uncertainty in quantitative PET , 2012, Acta radiologica short reports.

[15]  Christoph Hoeschen,et al.  A Compartmental Model for Biokinetics and Dosimetry of 18F-Choline in Prostate Cancer Patients , 2012, The Journal of Nuclear Medicine.

[16]  Stephen R. Thomas,et al.  MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry—Standardization of Nomenclature , 2009, Journal of Nuclear Medicine.

[17]  J. Valentin.  Basic anatomical and physiological data for use in radiological protection: reference values , 2002, Annals of the ICRP.

[18]  Stephen R Thomas,et al.  MIRD dose estimate report no. 19: radiation absorbed dose estimates from (18)F-FDG. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  M. Hays,et al.  A mathematical model for the distribution of fluorodeoxyglucose in humans. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  M. Stabin,et al.  MIRD Pamphlet No. 14 revised: A dynamic urinary bladder model for radiation dose calculations. Task Group of the MIRD Committee, Society of Nuclear Medicine. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  Masatoshi Itoh,et al.  Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-d- glucose using whole-body positron emission tomography and magnetic resonance imaging , 1998, European Journal of Nuclear Medicine.

[22]  C Cobelli,et al.  SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. , 1998, Metabolism: clinical and experimental.

[23]  J. Hatazawa,et al.  Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  K. F. Eckerman,et al.  Specific absorbed fractions of energy at various ages from internal photon sources: 2, One-year-old , 1987 .

[25]  K. F. Eckerman,et al.  Specific absorbed fractions of energy at various ages from internal photon sources: 6, Newborn , 1987 .

[26]  D Christman,et al.  The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  Michael G. Stabin,et al.  Radiation Dose to Patients from Radiopharmaceuticals , 2009 .

[28]  J. Valentin.  The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. , 2007, Annals of the ICRP.

[29]  内山 眞幸.  Annual Congress of the European Association of Nuclear Medicine , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[30]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[31]  C. Nahmias,et al.  Absorbed dose to the adult male and female brain from 18F-fluorodeoxyglucose. , 2001, Health physics.

[32]  E. Hoffman,et al.  Noninvasive determination of local cerebral metabolic rate of glucose in man. , 1980, The American journal of physiology.

[33]  Icrp.  Recommendations of the International Commission on Radiological Protection, ICRP Publication 26 , 1977 .